Emerging Medication in Australia: A New Solution for Obesity Management ?
Australia is closely watching the arrival of retatrutide, a cutting-edge dual GIP and GLP-1 receptor medication , representing a significant advance in weight loss . Early clinical trials have demonstrated impressive results, showing greater impact than existing treatments like semaglutide. While